Shopping Cart
- Remove All
- Your shopping cart is currently empty
CBB1007 trihydrochloride is a selective, reversible, and substrate competitive LSD1 inhibitor (IC50: 5.27 μM for hLSD1).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $140 | Backorder | |
5 mg | $207 | Backorder | |
10 mg | $314 | Backorder | |
50 mg | $739 | Backorder | |
100 mg | $1,148 | Backorder | |
200 mg | Inquiry | Backorder | |
500 mg | Inquiry | Backorder | |
1 mL x 10 mM (in DMSO) | $293 | Backorder |
Description | CBB1007 trihydrochloride is a selective, reversible, and substrate competitive LSD1 inhibitor (IC50: 5.27 μM for hLSD1). |
In vitro | CBB1007 efficiently can block LSD1-mediated demethylation of H3K4Me2 and H3K4Me (IC50 ≤ 5 μM) with no effect on H3K4Me3 and H3K9Me2, and LSD2 and JARID1A activities. Increases H3K4Me2 and H3K4Me contents (IC50 ≤ 5 μM), and causes activation of epigenetically suppressed CHRM4/M4-ArchR and SCN3A genes in F9 cells (IC50 ≤ 3.74 μM). |
Alias | CBB1007 trihydrochloride |
Cas No. | 2070015-03-9 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 54 mg/mL (83.85 mM) |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.